Lexeo Therapeutics is a New York City-based, clinical stage genetic medicine company dedicated to transforming healthcare by applying pioneering science to fundamentally change how genetically defined cardiovascular diseases are treated. Using a stepwise development approach, Lexeo is leveraging early proof-of-concept functional and biomarker data to advance a pipeline of rare cardiovascular disease programs focused on Friedreichâs ataxia (FA) cardiomyopathy and arrhythmogenic cardiomyopathy (ACM). Role Summary The Graduate intern will have the opportunity to make significant contributions to Lexeoâs portfolio management systems and strategy. With multiple interim data readouts expected in 2026, the Intern will help to shape planning, resourcing, budgeting and risk management as these complex gene therapy programs advance. Over the course of the summer, the intern will work to develop and improve systems for analyzing program data and metrics to better identify opportunities for improvement, providing recommendations and implementing new systems and/or strategies for cycle time improvement, clinical trial management and oversight and program execution.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Career Level
Intern